Latest stories on TARA
Protara Therapeutics Stockholders Approve Governance and Share Increases
TipRanks50 · neutralgeneral
Protara Therapeutics, Inc. (TARA) files 8-K
SEC 8-K50 · neutralgeneral
PROTARA THERAPEUTICS (TARA) news roundup. 2 stories in the last 24 hours, 2 in the past week, 4 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.